GR1008169B - Φαρμακευτικο σκευασμα περιεχον εναν αντιβακτηριακο παραγοντα φθοριοκινολονης και μεθοδος για την παρασκευη αυτου - Google Patents
Φαρμακευτικο σκευασμα περιεχον εναν αντιβακτηριακο παραγοντα φθοριοκινολονης και μεθοδος για την παρασκευη αυτουInfo
- Publication number
- GR1008169B GR1008169B GR20130100162A GR20130100162A GR1008169B GR 1008169 B GR1008169 B GR 1008169B GR 20130100162 A GR20130100162 A GR 20130100162A GR 20130100162 A GR20130100162 A GR 20130100162A GR 1008169 B GR1008169 B GR 1008169B
- Authority
- GR
- Greece
- Prior art keywords
- preparation
- pharmaceutical composition
- antibacterial agent
- fluoroquinolone antibacterial
- fluoroquinolone
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Abstract
Η παρούσα εφεύρεση αφορά σταθερό φαρμακευτικό σκεύασμα για χορήγηση διά στόματος αποτελούμενης από θεραπευτικά δραστική ποσότητα αντιβιοτικού φθοριοκινολονών ή κάποιου φαρμακευτικά αποδεκτού άλατος αυτών. Επίσης, η εφεύρεση αφορά και την μέθοδο παρασκευής του ως άνω σκευάσματος.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GR20130100162A GR1008169B (el) | 2013-03-19 | 2013-03-19 | Φαρμακευτικο σκευασμα περιεχον εναν αντιβακτηριακο παραγοντα φθοριοκινολονης και μεθοδος για την παρασκευη αυτου |
PCT/EP2014/000712 WO2014146775A1 (en) | 2013-03-19 | 2014-03-17 | Pharmaceutical composition comprising a fluoroquinolone antibacterial agent and method for the preparation thereof |
EP14715539.4A EP2976067B1 (en) | 2013-03-19 | 2014-03-17 | Pharmaceutical composition comprising a fluoroquinolone antibacterial agent and method for the preparation thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GR20130100162A GR1008169B (el) | 2013-03-19 | 2013-03-19 | Φαρμακευτικο σκευασμα περιεχον εναν αντιβακτηριακο παραγοντα φθοριοκινολονης και μεθοδος για την παρασκευη αυτου |
Publications (1)
Publication Number | Publication Date |
---|---|
GR1008169B true GR1008169B (el) | 2014-04-08 |
Family
ID=50440626
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GR20130100162A GR1008169B (el) | 2013-03-19 | 2013-03-19 | Φαρμακευτικο σκευασμα περιεχον εναν αντιβακτηριακο παραγοντα φθοριοκινολονης και μεθοδος για την παρασκευη αυτου |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP2976067B1 (el) |
GR (1) | GR1008169B (el) |
WO (1) | WO2014146775A1 (el) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107028904B (zh) * | 2017-05-15 | 2021-05-11 | 沈阳华泰药物研究有限公司 | 一种盐酸曲唑酮片的制备方法 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011034514A2 (en) * | 2009-09-18 | 2011-03-24 | Bilgic Mahmut | Stable micronized granules having high solubility |
WO2011086577A2 (en) * | 2010-01-12 | 2011-07-21 | Msn Laboratories Limited | Pharmaceutical composition of moxifloxacin and its pharmaceutically acceptable salts |
US20110293717A1 (en) * | 2008-12-08 | 2011-12-01 | Ratiopharm Gmbh | Compacted moxifloxacin |
EP2491921A1 (en) * | 2011-02-25 | 2012-08-29 | Deva Holding Anonim Sirketi | Conservation of anhydrous form of gemifloxacin |
FR2992218A1 (fr) * | 2012-06-22 | 2013-12-27 | Rivopharm Sa | Composition pharmaceutique de chlorhydrate de moxifloxacine et procede de preparation |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2239931A1 (en) * | 1998-07-15 | 2000-01-15 | Bernard Charles Sherman | Pharmaceutical tablet comprising norfloxacin |
WO2003101431A1 (en) * | 2002-06-04 | 2003-12-11 | J.B. Chemicals & Pharmaceuticals Ltd. | Pharmaceutical composition for controlled drug delivery system |
EP1663226A1 (en) * | 2003-09-03 | 2006-06-07 | Ranbaxy Laboratories Limited | Pharmaceutical compositions of moxifloxacin and processes for their preparation |
EP1880722B1 (en) * | 2006-07-19 | 2010-03-17 | Tabuk Pharmaceutical Manufacturing Co. | Pharmaceutical compositions of ciprofloxacin |
-
2013
- 2013-03-19 GR GR20130100162A patent/GR1008169B/el active IP Right Grant
-
2014
- 2014-03-17 EP EP14715539.4A patent/EP2976067B1/en active Active
- 2014-03-17 WO PCT/EP2014/000712 patent/WO2014146775A1/en active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110293717A1 (en) * | 2008-12-08 | 2011-12-01 | Ratiopharm Gmbh | Compacted moxifloxacin |
WO2011034514A2 (en) * | 2009-09-18 | 2011-03-24 | Bilgic Mahmut | Stable micronized granules having high solubility |
WO2011086577A2 (en) * | 2010-01-12 | 2011-07-21 | Msn Laboratories Limited | Pharmaceutical composition of moxifloxacin and its pharmaceutically acceptable salts |
EP2491921A1 (en) * | 2011-02-25 | 2012-08-29 | Deva Holding Anonim Sirketi | Conservation of anhydrous form of gemifloxacin |
FR2992218A1 (fr) * | 2012-06-22 | 2013-12-27 | Rivopharm Sa | Composition pharmaceutique de chlorhydrate de moxifloxacine et procede de preparation |
Also Published As
Publication number | Publication date |
---|---|
EP2976067A1 (en) | 2016-01-27 |
WO2014146775A1 (en) | 2014-09-25 |
EP2976067B1 (en) | 2021-12-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12018501807A1 (en) | Pyrazolopyrrolidine derivatives and their use in the treatment of diseas | |
NZ732154A (en) | Bile acid derivatives as fxr/tgr5 agonists and methods of use thereof | |
MX2015016344A (es) | Derivados de imidazo-pirrolidinona y su uso en el tratamiento de enfermedades. | |
MX2015016421A (es) | Derivados de pirazolo-pirrolidin-4-ona como inhibidores de bet y su uso en el tratamiento de enfermedades. | |
EP3256149A4 (en) | FORMULATIONS FOR ORAL ADMINISTRATION OF ACTIVE AGENTS | |
IN2015DN01673A (el) | ||
MX2015016425A (es) | Derivados de pirazolo-pirrolidin-4-ona y su uso en el tratamiento de enfermedades. | |
WO2013188273A8 (en) | Topical ophthalmological pharmaceutical composition containing axitinib | |
EA032271B9 (ru) | Вещества, фармацевтическая композиция и методы применения при лечении воспалительных заболеваний | |
WO2013188268A8 (en) | Topical ophthalmological pharmaceutical composition containing pazopanib | |
MX2016001422A (es) | Composicion farmaceutica de fingolimod. | |
TN2013000533A1 (en) | Topical ophthalmological pharmaceutical composition containing regorafenib | |
IL282163A (en) | A pharmaceutical preparation for oral administration containing an aminopyrimidine derivative or its salt | |
MX2017013099A (es) | Metodos para el tratamiento de trastornos inflamatorios. | |
GR1008228B (el) | Φαρμακευτικο σκευασμα περιεχον ενα διπλο αναστολεα επαναπροσληψης και μεθοδος για την παρασκευη αυτου | |
MX2016006667A (es) | Derivados de pirrolo-pirrolona y su uso como inhibidores. | |
MX2015007488A (es) | Composicion farmaceutica oftalmologica topica que contiene regorafenib. | |
WO2013188279A8 (en) | Topical ophthalmological pharmaceutical composition containing cediranib | |
TR201310724A2 (tr) | Linagliptinin farmasotik formulasyonları. | |
GR1008169B (el) | Φαρμακευτικο σκευασμα περιεχον εναν αντιβακτηριακο παραγοντα φθοριοκινολονης και μεθοδος για την παρασκευη αυτου | |
MX2015017124A (es) | Combinacion de ro5503781, capecitabina y oxaliplatino para la terapia para el cancer. | |
GR1008819B (el) | Φαρμακευτικο σκευασμα που περιλαμβανει ατομοξετινη και μεθοδος παρασκευης αυτου | |
GR1008821B (el) | Φαρμακευτικο σκευασμα που περιλαμβανει υδροχλωρικη ιβαμπραδινη και μεθοδος παρασκευης αυτου | |
EP3010534A4 (en) | Pharmaceutical formulations and methods for oral delivery of biologically active ingredient | |
EA201500366A1 (ru) | Применение 1-адамантилетилокси-3-морфолино-2-пропанола или его фармацевтически приемлемых солей в фармацевтических композициях в качестве нейроретинопротектора |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PG | Patent granted |
Effective date: 20140515 |